Cite
TMEM106B the first common risk factor for FTLD: Replication in a clinically diagnosed cohort of FTLD patients.
MLA
van der Zee, Julie, et al. “TMEM106B the First Common Risk Factor for FTLD: Replication in a Clinically Diagnosed Cohort of FTLD Patients.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 6, no. 4, July 2010, pp. S75–76. EBSCOhost, https://doi.org/10.1016/j.jalz.2010.05.224.
APA
van der Zee, J., Van Langenhove, T., Kleinberger, G., Sleegers, K., Engelborghs, S., Vandenberghe, R., Santens, P., Cras, P., De Deyn, P. P., Cruts, M., & Van Broeckhoven, C. (2010). TMEM106B the first common risk factor for FTLD: Replication in a clinically diagnosed cohort of FTLD patients. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 6(4), S75–S76. https://doi.org/10.1016/j.jalz.2010.05.224
Chicago
van der Zee, Julie, Tim Van Langenhove, Gernot Kleinberger, Kristel Sleegers, Sebastiaan Engelborghs, Rik Vandenberghe, Patrick Santens, et al. 2010. “TMEM106B the First Common Risk Factor for FTLD: Replication in a Clinically Diagnosed Cohort of FTLD Patients.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 6 (4): S75–76. doi:10.1016/j.jalz.2010.05.224.